The ISTH Congress always presents an impressive lineup of plenary speakers, and ISTH 2015 in Toronto promises to continue that tradition with plenaries from five prestigious global leaders in the thrombosis and hemostasis community. See below for information on these internationally recognized speakers. Visit ISTH2015.org to register.
Paul Kubes (Canada) |Platelets and Immunity
Paul Kubes is a Professor at the University of Calgary Faculty of Medicine and Founding Director of the Snyder Institute for Chronic Diseases at the University. He also holds a Canada Research Chair in Leukocyte Recruitment in inflammatory disease. Kubes has been named the Canada's Health Researcher of the Year by the Canadian Institutes of Health Research (CIHR) for his work in examining the role that white blood cells play in preventing and reversing sepsis.
Eugene Braunwald (USA) |75 years of Progress in Antithrombotic Therapy for Cardiovascular Disease
Often called the father of modern cardiology, Eugene Braunwald is theHersey Professor of Medicine at Harvard Medical School.Science Watchhas listed Braunwald as the most frequently cited author in cardiology. Beyond numerous awards and 20 honorary degrees, he was the first cardiologist elected to the National Academy of Sciences.
David Ginsburg (USA) |Genetics of Thrombosis: From Mice to Humans
David Ginsburg is the James V. Neel Distinguished University Professor of Internal Medicine, Human Genetics, and Pediatrics at the U-M Medical School, a member of the U-M Life Sciences Institute, and an Investigator of the Howard Hughes Medical Institute.He is credited with identifying the genetic basis of numerous clotting disorders, such as thrombotic thrombocytopenic purpura (TTP), combined deficiency of Factor V and Factor VIII, and von Willebrand disease (VWD).
Stefanie Dimmeler (Germany) |Non-Coding RNAs: Novel Therapeutic Targets in Cardiovascular Disease
Stefanie Dimmeler is Professor of Experimental Medicine and Director of the Institute of Cardiovascular Regeneration, Center for Molecular Medicine at the University of Frankfurt.She has received several awards including the prestigious Alfried Krupp Award 2002 (500,000 €), the Leibniz Award 2005 (1.5 Million €), the Award of the Jung Foundation 2007 and the FEBS award 2006.
Brian McCrindle (Canada) |Why Do We Miss the Mark on Preventing Cardiovascular Disease? Is it Too Little, Too Late?
Brian McCrindle is a Co-Director/Statistical Consultant for the CHSS Data Center and is a Cardiologist at the Hospital for Sick Children in Toronto. He obtained his BMedSc, M.D. at the University of Alberta in Edmonton, Canada, and continued to complete his FRCPC, MPH from Johns Hopkins University in Baltimore, M.D. He is theonly non-surgeon full-member of the Congenital Heart Surgeons’ Society.
The ISTH 2015 Congress is a unique opportunity to gather with these and other global leaders in thrombosis and hemostasis to discover the newest science and clinical practices.